The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
申请公布号
WO2017015449(A1)
申请公布日期
2017.01.26
申请号
WO2016US43320
申请日期
2016.07.21
申请人
ENANTA PHARMACEUTICALS, INC.
发明人
SHOOK, Brian, C.;KIM, In, Jong;BLAISDELL, Thomas, P.;YU, Jianming;PANARESE, Joseph;OR, Yat, Sun